Igc says fda approves initiation of co's cannabinoid trial on alzheimer's patients

Fda approves initiation of igc’s cannabinoid trial on alzheimer’s patients.india globalization capital inc - announces fda removal of clinical hold for multiple ascending dose study of igc-ad1.
IGC Ratings Summary
IGC Quant Ranking